How often to get blood work

Retesting has a natural rhythm for each marker. HbA1c reflects the last two to three months, so a repeat after four weeks is still mostly measuring the time before. hs-CRP moves within days, so one value is closer to a weather report than a climate. Lp(a) barely moves in a lifetime. The guidelines set intervals with that in mind, and when nothing is changing, they are longer than most people expect.

The guideline intervals

Why HbA1c has a floor

HbA1c is glucose stuck to haemoglobin, and red cells live roughly three months. A result is a weighted average of that lifespan, with recent weeks counting more. That is why the ADA ties more frequent testing to treatment changes at about three-month intervals. If you start a GLP-1 or a new protocol and test HbA1c four weeks later, most of what you see is still the period before you started. Fasting glucose and fasting insulin respond faster, which is one reason they are drawn alongside.

Matching the interval to the change

A useful way to think about any repeat: something has changed, the marker can respond to it, and enough time has passed for the response to show. Some rough response times, from the biology:

• Days: hs-CRP, IL-6, white cell count, glucose, triglycerides after diet change, ALT and AST after exercise.
• Weeks: LDL after starting a statin (hence the 4 to 12 week check), ferritin after iron, creatinine after a large change in muscle or hydration.
• Two to three months: HbA1c, vitamin D after a dose change, haemoglobin recovering from iron deficiency.
• Essentially never: Lp(a).

On a GLP-1

There is no fixed interval for weight management without diabetes; the prescriber sets it. A common shape is a baseline before the first dose, a check around three months when HbA1c can reflect the drug, and then at intervals the prescriber chooses, with extra kidney checks after any spell of severe vomiting or diarrhoea, which the labels warn about. With diabetes, the ADA's three-monthly rhythm after a treatment change applies. The GLP-1 blood work page has the detail.

On a new protocol without a label

For research compounds there is no guideline at all. The pattern people with clinicians usually follow mirrors the GLP-1 one: a baseline, a repeat once the compound has had time to act on the markers of interest, and then less often if nothing is moving. For a long-acting compound, the days since the last dose change the result, so the draw date relative to dosing matters as much as the interval. The peptide blood testing page covers which markers and why.

Retesting a surprising result

A single unexpected value is often repeated before anyone acts on it, and for good reason. Many markers vary a lot within the same person. hs-CRP's within-person variation is around 44 percent on median, according to a 2024 meta-analysis, so a doubling between two draws can happen with nothing changed. The biological variation page shows how to calculate how big a change needs to be to mean something. For hs-CRP above 10 mg/L, the CDC/AHA statement says to repeat it once any acute illness has passed.

More testing is not more information

Each draw carries its own noise. Testing every month on a stable protocol produces a line that wiggles without meaning, and every wiggle invites a decision. A smaller number of well-timed draws, under the same conditions, at the same lab, gives a cleaner picture. The preparation guide covers how to keep conditions the same.

Timing a draw around a change

The most useful draws bracket a change. One just before you start a medicine, a protocol, a diet or a training block, and one once the markers you care about have had time to respond. Two habits make those pairs readable. First, avoid changing several things in the weeks before the second draw, because a result cannot tell you which change moved it. Second, keep the conditions of the two draws the same, since a fasted morning draw compared with an afternoon one after lunch is a comparison of two different tests. Annual bloodwork is a reasonable habit for many people, but its value comes from being comparable year to year, not from the calendar.

Seeing the gaps

In Peptide AI, every draw is a point on the same timeline as the dose log and protocol planner, so it is easy to see whether a draw landed three weeks or three months after a change. Bloodwork tracking covers how results go in.